|
NDC00015-3020-97
|
6505-01-377-3225
|
Usp Amikacin Sulfate Injection |
Bristol-myers Squibb Pharmaceutical
|
|
Quote
|
|
NDC00641-0123-23
|
6505-01-377-3225
|
Usp Amikacin Sulfate Injection |
Elkins-sinn Inc
|
|
Quote
|
|
NDC00015-3020-20
|
6505-01-377-3225
|
Usp Amikacin Sulfate Injection |
Bristol-myers Squibb Pharmaceutical
|
|
Quote
|
|
P5581
|
6505-01-377-3483
|
Theophylline In Dextrose Injecti |
B Braun Medical Inc
|
|
Quote
|
|
NDC00264-9558-10
|
6505-01-377-3483
|
Theophylline In Dextrose Injecti |
B Braun Medical Inc
|
|
Quote
|
|
NDC00270-1314-34
|
6505-01-377-6530
|
Usp Iopamidol Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
ISOVUE-370
|
6505-01-377-6533
|
Usp Iopamidol Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
04-1656
|
6505-01-377-6533
|
Usp Iopamidol Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC00270-1316-47
|
6505-01-377-6533
|
Usp Iopamidol Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
NDC00270-1316-52
|
6505-01-377-6534
|
Usp Iopamidol Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
NDC00270-1316-52
|
6505-01-377-6534
|
Usp Iopamidol Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
NDC00270-2153-10
|
6505-01-377-6535
|
Usp Iopamidol Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
NDC00270-2153-10
|
6505-01-377-6535
|
Usp Iopamidol Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
NDC00003-0154-50
|
6505-01-377-6540
|
Pravastatin Sodium Tablets |
Bristol-myers Squibb Pharmaceutical
|
|
Quote
|
|
PRAVACHOL
|
6505-01-377-6540
|
Pravastatin Sodium Tablets |
Bristol-myers Squibb Pharmaceutical
|
|
Quote
|
|
NDC00003-0154-50
|
6505-01-377-6540
|
Pravastatin Sodium Tablets |
Bristol-myers Squibb Pharmaceutical
|
|
Quote
|
|
PRAVACHOL
|
6505-01-377-6540
|
Pravastatin Sodium Tablets |
Bristol-myers Squibb Pharmaceutical
|
|
Quote
|
|
NDC00006-0019-94
|
6505-01-377-8060
|
Usp Lisinopril Tablets |
Merck and Co Inc
|
|
Quote
|
|
PRINIVIL
|
6505-01-377-8061
|
Usp Lisinopril Tablets |
Merck and Co Inc
|
|
Quote
|
|
NDC00006-0019-87
|
6505-01-377-8061
|
Usp Lisinopril Tablets |
Merck and Co Inc
|
|
Quote
|
|
NDC00006-0106-94
|
6505-01-377-8063
|
Usp Lisinopril Tablets |
Merck and Co Inc
|
|
Quote
|
|
PRINIVIL
|
6505-01-377-8064
|
Usp Lisinopril Tablets |
Merck and Co Inc
|
|
Quote
|
|
NDC00006-0106-87
|
6505-01-377-8064
|
Usp Lisinopril Tablets |
Merck and Co Inc
|
|
Quote
|
|
NDC00006-0207-94
|
6505-01-377-8065
|
Usp Lisinopril Tablets |
Merck and Co Inc
|
|
Quote
|
|
PRINIVIL
|
6505-01-377-8066
|
Usp Lisinopril Tablets |
Merck and Co Inc
|
|
Quote
|
|
PRINIVIL TABLETS
|
6505-01-377-8066
|
Usp Lisinopril Tablets |
Merck and Co Inc
|
|
Quote
|
|
NDC00006-0207-87
|
6505-01-377-8066
|
Usp Lisinopril Tablets |
Merck and Co Inc
|
|
Quote
|
|
NDC00089-0302-03
|
6505-01-377-8068
|
Nitroglycerin Transdermal System |
3m Company
|
|
Quote
|
|
NDC00089-0302-03
|
6505-01-377-8068
|
Nitroglycerin Transdermal System |
Minnesota Mining and Mfg Co
|
|
Quote
|
|
NDC00089-0304-03
|
6505-01-377-8069
|
Nitroglycerin Transdermal System |
3m Company
|
|
Quote
|
|
NDC00089-0304-03
|
6505-01-377-8069
|
Nitroglycerin Transdermal System |
Minnesota Mining and Mfg Co
|
|
Quote
|
|
NDC00089-0303-03
|
6505-01-377-8070
|
Nitroglycerin Transdermal System |
3m Company
|
|
Quote
|
|
NDC00089-0303-03
|
6505-01-377-8070
|
Nitroglycerin Transdermal System |
Minnesota Mining and Mfg Co
|
|
Quote
|
|
NDC00089-0301-03
|
6505-01-377-8081
|
Nitroglycerin Transdermal System |
3m Company
|
|
Quote
|
|
NDC00089-0301-03
|
6505-01-377-8081
|
Nitroglycerin Transdermal System |
Minnesota Mining and Mfg Co
|
|
Quote
|
|
TEST 1 BRAND
|
6505-01-377-8146
|
Usp Aspirin Tablets |
U S Dept of Veterans Affairs
|
|
Quote
|
|
GENTRAN 40
|
6505-01-377-8904
|
Dextran 40 And Dextrose Injectio |
Baxter Healthcare Corp
|
|
Quote
|
|
F93G104
|
6505-01-377-8904
|
Dextran 40 And Dextrose Injectio |
Air Force Medical Logistics Office
|
|
Quote
|
|
2B50530
|
6505-01-377-8904
|
Dextran 40 And Dextrose Injectio |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC00338-0272-03
|
6505-01-377-8904
|
Dextran 40 And Dextrose Injectio |
Cardinal Health 200, Llc
|
|
Quote
|
|
2B5053
|
6505-01-377-8904
|
Dextran 40 And Dextrose Injectio |
Baxter Healthcare Corp
|
|
Quote
|
|
2B50530
|
6505-01-377-8904
|
Dextran 40 And Dextrose Injectio |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0272-03
|
6505-01-377-8904
|
Dextran 40 And Dextrose Injectio |
Baxter Healthcare Corp
|
|
Quote
|
|
SCHISTOSOME ANTIPENETRANT
|
6505-01-377-9228
|
Niclosamide Lotion |
Bayer Corp
|
|
Quote
|
|
DURICEF
|
6505-01-377-9831
|
U Cefadroxil For Oral Suspension |
Mead Johnson & Company, Llc
|
|
Quote
|
|
ULTRACEF
|
6505-01-377-9831
|
U Cefadroxil For Oral Suspension |
Bristol-myers Squibb Co
|
|
Quote
|
|
NDC00087-0782-42
|
6505-01-377-9831
|
U Cefadroxil For Oral Suspension |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00087-0782-42
|
6505-01-377-9831
|
U Cefadroxil For Oral Suspension |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00015-7284-25
|
6505-01-377-9831
|
U Cefadroxil For Oral Suspension |
Mead Johnson & Company, Llc
|
|
Quote
|
|
22-9803
|
6505-01-378-0228
|
Protein Supplement Powder |
Bimeco Inc
|
|
Quote
|
|
NDC00034-0515-50
|
6505-01-378-0251
|
Morphine Sulfate Extended-releas |
The Frederick Purdue Company
|
|
Quote
|
|
ORAMORPH SR
|
6505-01-378-0251
|
Morphine Sulfate Extended-releas |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
ORAMORPH SR TABELTS
|
6505-01-378-0251
|
Morphine Sulfate Extended-releas |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00054-4805-19
|
6505-01-378-0251
|
Morphine Sulfate Extended-releas |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00467-6510-15
|
6505-01-378-0485
|
Potassium Chloride For Injection |
Lyphomed Inc
|
|
Quote
|
|
NAFTIN
|
6505-01-378-1370
|
Usp Naftifine Hydrochloride Gel |
Allergan Inc
|
|
Quote
|
|
NDC00023-4770-40
|
6505-01-378-1370
|
Usp Naftifine Hydrochloride Gel |
Allergan Inc
|
|
Quote
|
|
NDC00259-4770-40
|
6505-01-378-1370
|
Usp Naftifine Hydrochloride Gel |
Merz Incorporated
|
|
Quote
|
